Cargando…
Acupuncture for menstruation-related migraine prophylaxis: A multicenter randomized controlled trial
OBJECTIVE: The aim of this study was to evaluate the efficacy of acupuncture, an alternative medicine therapy, as a preventive treatment for menstruation-related migraine (MRM). PATIENTS AND METHODS: This was a prospective, multicenter, double-dummy, participant-blinded, randomized controlled clinic...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459087/ https://www.ncbi.nlm.nih.gov/pubmed/36090267 http://dx.doi.org/10.3389/fnins.2022.992577 |
_version_ | 1784786426203734016 |
---|---|
author | Liu, Lu Zhang, Claire-Shuiqing Liu, Hui-Lin He, Fan Lyu, Tian-Li Zeng, Lin Zhao, Luo-Peng Wang, Mi-Na Qu, Zheng-Yang Nie, Li-Min Guo, Jia Zhang, Xiao-Zhe Lu, Yong-Hui Wang, Ke-Lun Li, Bin Jing, Xiang-Hong Wang, Lin-Peng |
author_facet | Liu, Lu Zhang, Claire-Shuiqing Liu, Hui-Lin He, Fan Lyu, Tian-Li Zeng, Lin Zhao, Luo-Peng Wang, Mi-Na Qu, Zheng-Yang Nie, Li-Min Guo, Jia Zhang, Xiao-Zhe Lu, Yong-Hui Wang, Ke-Lun Li, Bin Jing, Xiang-Hong Wang, Lin-Peng |
author_sort | Liu, Lu |
collection | PubMed |
description | OBJECTIVE: The aim of this study was to evaluate the efficacy of acupuncture, an alternative medicine therapy, as a preventive treatment for menstruation-related migraine (MRM). PATIENTS AND METHODS: This was a prospective, multicenter, double-dummy, participant-blinded, randomized controlled clinical trial conducted in China between 1 April 2013, and 30 April 2014. The participants were enrolled from four study centers and randomized to into either the acupuncture group, which received 24 sessions of acupuncture at traditional acupoints plus placebo, or the medication group, which received sham acupuncture plus naproxen. The primary endpoint was change from the baseline average number of migraine days per perimenstrual period over cycles 1−3. The secondary endpoints included changes from the baseline average number of migraine days outside the perimenstrual period, mean number of migraine hours during and outside the perimenstrual period, mean visual analog scale score during and outside the perimenstrual period, ≥50% migraine responder rate, and the proportion of participants who used acute pain medication over cycles 1−3 and 4−6. RESULTS: A total of 172 women with MRM were enrolled; 170 in the intention-to-treat analyses. Our primary outcome reported a significant between-group difference that favored the acupuncture group (95% CI, 0.17–0.50; P < 0.001), with the average reduction of migraine days per perimenstrual period from the baseline was 0.94 (95% CI, 0.82–1.07) in the acupuncture group and 0.61 (95% CI, 0.50–0.71) in the medication group over cycles 1−3. CONCLUSION: This study showed that compared to medication, acupuncture reduces the number of migraine days experienced by patients with MRM. For patients who received the acupuncture treatment over three cycles, the preventive effect of the therapy was sustained for six cycles. CLINICAL TRIAL REGISTRATION: [https://www.isrctn.com/ISRCTN57133712], identifier [ISRCTN15663606]. |
format | Online Article Text |
id | pubmed-9459087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94590872022-09-10 Acupuncture for menstruation-related migraine prophylaxis: A multicenter randomized controlled trial Liu, Lu Zhang, Claire-Shuiqing Liu, Hui-Lin He, Fan Lyu, Tian-Li Zeng, Lin Zhao, Luo-Peng Wang, Mi-Na Qu, Zheng-Yang Nie, Li-Min Guo, Jia Zhang, Xiao-Zhe Lu, Yong-Hui Wang, Ke-Lun Li, Bin Jing, Xiang-Hong Wang, Lin-Peng Front Neurosci Neuroscience OBJECTIVE: The aim of this study was to evaluate the efficacy of acupuncture, an alternative medicine therapy, as a preventive treatment for menstruation-related migraine (MRM). PATIENTS AND METHODS: This was a prospective, multicenter, double-dummy, participant-blinded, randomized controlled clinical trial conducted in China between 1 April 2013, and 30 April 2014. The participants were enrolled from four study centers and randomized to into either the acupuncture group, which received 24 sessions of acupuncture at traditional acupoints plus placebo, or the medication group, which received sham acupuncture plus naproxen. The primary endpoint was change from the baseline average number of migraine days per perimenstrual period over cycles 1−3. The secondary endpoints included changes from the baseline average number of migraine days outside the perimenstrual period, mean number of migraine hours during and outside the perimenstrual period, mean visual analog scale score during and outside the perimenstrual period, ≥50% migraine responder rate, and the proportion of participants who used acute pain medication over cycles 1−3 and 4−6. RESULTS: A total of 172 women with MRM were enrolled; 170 in the intention-to-treat analyses. Our primary outcome reported a significant between-group difference that favored the acupuncture group (95% CI, 0.17–0.50; P < 0.001), with the average reduction of migraine days per perimenstrual period from the baseline was 0.94 (95% CI, 0.82–1.07) in the acupuncture group and 0.61 (95% CI, 0.50–0.71) in the medication group over cycles 1−3. CONCLUSION: This study showed that compared to medication, acupuncture reduces the number of migraine days experienced by patients with MRM. For patients who received the acupuncture treatment over three cycles, the preventive effect of the therapy was sustained for six cycles. CLINICAL TRIAL REGISTRATION: [https://www.isrctn.com/ISRCTN57133712], identifier [ISRCTN15663606]. Frontiers Media S.A. 2022-08-26 /pmc/articles/PMC9459087/ /pubmed/36090267 http://dx.doi.org/10.3389/fnins.2022.992577 Text en Copyright © 2022 Liu, Zhang, Liu, He, Lyu, Zeng, Zhao, Wang, Qu, Nie, Guo, Zhang, Lu, Wang, Li, Jing and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Liu, Lu Zhang, Claire-Shuiqing Liu, Hui-Lin He, Fan Lyu, Tian-Li Zeng, Lin Zhao, Luo-Peng Wang, Mi-Na Qu, Zheng-Yang Nie, Li-Min Guo, Jia Zhang, Xiao-Zhe Lu, Yong-Hui Wang, Ke-Lun Li, Bin Jing, Xiang-Hong Wang, Lin-Peng Acupuncture for menstruation-related migraine prophylaxis: A multicenter randomized controlled trial |
title | Acupuncture for menstruation-related migraine prophylaxis: A multicenter randomized controlled trial |
title_full | Acupuncture for menstruation-related migraine prophylaxis: A multicenter randomized controlled trial |
title_fullStr | Acupuncture for menstruation-related migraine prophylaxis: A multicenter randomized controlled trial |
title_full_unstemmed | Acupuncture for menstruation-related migraine prophylaxis: A multicenter randomized controlled trial |
title_short | Acupuncture for menstruation-related migraine prophylaxis: A multicenter randomized controlled trial |
title_sort | acupuncture for menstruation-related migraine prophylaxis: a multicenter randomized controlled trial |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459087/ https://www.ncbi.nlm.nih.gov/pubmed/36090267 http://dx.doi.org/10.3389/fnins.2022.992577 |
work_keys_str_mv | AT liulu acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT zhangclaireshuiqing acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT liuhuilin acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT hefan acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT lyutianli acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT zenglin acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT zhaoluopeng acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT wangmina acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT quzhengyang acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT nielimin acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT guojia acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT zhangxiaozhe acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT luyonghui acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT wangkelun acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT libin acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT jingxianghong acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial AT wanglinpeng acupunctureformenstruationrelatedmigraineprophylaxisamulticenterrandomizedcontrolledtrial |